BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34934812)

  • 1. Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs.
    Kuhlin J; Sturkenboom MGG; Ghimire S; Margineanu I; van den Elsen SHJ; Simbar N; Akkerman OW; Jongedijk EM; Koster RA; Bruchfeld J; Touw DJ; Alffenaar JC
    Clin Mass Spectrom; 2019 Sep; 14 Pt A():34-45. PubMed ID: 34934812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
    Mercier T; Desfontaine V; Cruchon S; Da Silva Pereira Clara JA; Briki M; Mazza-Stalder J; Kajkus A; Burger R; Suttels V; Buclin T; Opota O; Koehler N; Sanchez Carballo PM; Lange C; André P; Decosterd LA; Choong E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1211():123456. PubMed ID: 36240540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
    Herrera-Pérez IG; Rodríguez-Báez AS; Ortiz-Álvarez A; Velarde-Salcedo R; Arriaga-García FJ; Rodríguez-Pinal CJ; Romano-Moreno S; Milán-Segovia RDC; Medellín-Garibay SE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug; 1228():123801. PubMed ID: 37453389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring.
    Bolhuis MS; Akkerman OW; Sturkenboom MG; de Lange WC; van der Werf TS; Alffenaar JC
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S44-S45. PubMed ID: 28043603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of Chromatographic Methods Coupled with Modern Detection Techniques Applied in the Therapeutic Drugs Monitoring (TDM).
    Tuzimski T; Petruczynik A
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32899296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High perfomance liquid chromatography in pharmaceutical analyses.
    Nikolin B; Imamović B; Medanhodzić-Vuk S; Sober M
    Bosn J Basic Med Sci; 2004 May; 4(2):5-9. PubMed ID: 15629016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume.
    Vu DH; Koster RA; Alffenaar JW; Brouwers JR; Uges DR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1063-70. PubMed ID: 21459055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex Assay of Second-Line Anti-Tuberculosis Drugs in Dried Blood Spots Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry.
    Lee K; Jun SH; Han M; Song SH; Park JS; Lee JH; Park KU; Song J
    Ann Lab Med; 2016 Sep; 36(5):489-93. PubMed ID: 27374716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management.
    Thu NQ; Tien NTN; Yen NTH; Duong TH; Long NP; Nguyen HT
    J Pharm Anal; 2024 Jan; 14(1):16-38. PubMed ID: 38352944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Single-Run HPLC-MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis.
    Köhler N; Karaköse H; Grobbel HP; Hillemann D; Andres S; König C; Kalsdorf B; Brehm TT; Böttcher L; Friesen I; Hoffmann H; Strelec D; Schaub D; Peloquin CA; Schmiedel S; Decosterd LA; Choong E; Wicha SG; Aarnoutse RE; Lange C; Sánchez Carballo PM
    Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update.
    Briki M; Murisier A; Guidi M; Seydoux C; Buclin T; Marzolini C; Girardin FR; Thoma Y; Carrara S; Choong E; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Apr; 1236():124039. PubMed ID: 38490042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method for simultaneous analysis of nine second-line anti-tuberculosis drugs using UPLC-MS/MS.
    Han M; Jun SH; Lee JH; Park KU; Song J; Song SH
    J Antimicrob Chemother; 2013 Sep; 68(9):2066-73. PubMed ID: 23657802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of 5- fluorouracil, capecitabine and its metabolite concentrations in blood using volumetric absorptive microsampling technology and LC-MS/MS.
    Radovanovic M; Schneider JJ; Shafiei M; Martin JH; Galettis P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan; 1188():123075. PubMed ID: 34891049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of a liquid chromatography-tandem mass spectrometry assay in small hair samples for rifampin-resistant tuberculosis drug concentrations in a routine care setting.
    Metcalfe J; Bacchetti P; Esmail A; Reckers A; Aguilar D; Wen A; Huo S; Muyindike WR; Hahn JA; Dheda K; Gandhi M; Gerona R
    BMC Infect Dis; 2021 Jan; 21(1):99. PubMed ID: 33482745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma.
    Spaggiari D; Desfontaine V; Cruchon S; Guinchard S; Vocat A; Blattes E; Pitteloud J; Ciullini L; Bardinet C; Ivanyuk A; Makarov V; Ryabova O; Buclin T; Cole ST; Decosterd LA
    PLoS One; 2019; 14(5):e0217139. PubMed ID: 31150423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A semi-automated, isotope-dilution high-resolution mass spectrometry assay for therapeutic drug monitoring of antidepressants.
    Lindner JM; Vogeser M; Sorg K; Grimm SH
    Clin Mass Spectrom; 2019 Nov; 14 Pt B():89-98. PubMed ID: 34917765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma.
    Zheng X; Jongedijk EM; Hu Y; Kuhlin J; Zheng R; Niward K; Paues J; Xu B; Davies Forsman L; Schön T; Bruchfeld J; Alffenaar JC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1158():122397. PubMed ID: 33091676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of first-line anti-tuberculosis drugs and one metabolite of isoniazid by liquid chromatography/tandem mass spectrometry in patients with human immunodeficiency virus-tuberculosis coinfection.
    Xing Y; Yin L; Le X; Chen J; Zhang L; Li Y; Lu H; Zhang L
    Heliyon; 2021 Jul; 7(7):e07532. PubMed ID: 34296020
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.